Target intelligence / Profile preview

Pyolysin (PLO)

Target
PLO
Molecular classification
Cholesterol-dependent cytolysin (CDC), Pore-forming toxin (PFT), Bacterial exotoxin
01

Overview

Pyolysin (PLO) is a cholesterol-dependent cytolysin (CDC) produced by the Gram-positive bacterium Trueperella pyogenes, a significant pathogen in veterinary medicine. As a pore-forming toxin, PLO specifically targets and binds to cholesterol in the plasma membranes of host cells, such as macrophages, neutrophils, and endometrial cells. Upon binding, the toxin undergoes a conformational change to form large, stable pores that disrupt the osmotic balance of the cell, leading to rapid lysis and death. This process is the primary mechanism by which T. pyogenes causes diseases like bovine metritis and mastitis, as the destruction of immune cells allows the bacteria to evade the host's defense systems. Because PLO is essential for the pathogenicity of the bacterium, it is a key target for the development of veterinary vaccines and neutralizing antibody therapies. Current research focuses on inhibiting the toxin's binding or oligomerization phases to protect livestock from infection-related reproductive and systemic damage.

Other names
Pyolysin OPLO toxinTrueperella pyogenes pore-forming toxinArcanobacterium pyogenes cytolysin
02

Mechanism of action

Pyolysin acts as a pore-forming toxin by binding to cholesterol in the host cell membrane, where it oligomerizes to form large transmembrane pores that lead to osmotic lysis and cell death.

03

Biological functions

Pore formationCytolysisCell deathVirulence factorImmune evasion
04

Disease associations

InfectionBovine metritisMastitisLiver abscessesEndometritis
05

Safety considerations

Potent cytotoxicity to immune cellsHigh virulence in livestockRisk of severe tissue necrosisSpecies-specific activity primarily in ungulates
06

Interacting drugs

Beta-cyclodextrin

3 more in the full profile.

07

Biomarkers

Anti-PLO antibodiesTrueperella pyogenes DNALactate dehydrogenase (LDH) release

Beyond the preview

Go deeper on Pyolysin (PLO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pyolysin (PLO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call